GC
BSX icon

Gould Capital’s Boston Scientific BSX Stock Holding History

Gould Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-123
Closed -$9.47K – 218
2024
Q2 		$9.47K Buy
+123
New +$9K 0.01% 145
2023
Q3 		– Sell
-18,862
Closed -$1.02M – 196
2023
Q2 		$1.02M Sell
18,862
-720
-4% -$37.6K 0.78% 33
2023
Q1 		$980K Sell
19,582
-4,279
-18% -$202K 0.76% 33
2022
Q4 		$1.1M Sell
23,861
-305
-1% -$13.2K 0.88% 31
2022
Q3 		$936K Sell
24,166
-162
-0.7% -$6.5K 0.81% 33
2022
Q2 		$907K Sell
24,328
-903
-4% -$36.8K 0.73% 37
2022
Q1 		$1.12M Buy
+25,231
New +$1.09M 0.8% 33

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Gould Capital's BSX Position: Q3 2024 in Review

Gould Capital sold out of Boston Scientific (BSX) in Q3 2024, closing a stake of 123 shares — an estimated $9.47K sold.

Gould Capital first reported a position in BSX in Q1 2022 and held it in 7 quarters. The position peaked at $1.12M in Q1 2022. 1,395 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

  • Gould Capital reported no remaining Boston Scientific position as of Q3 2024 after selling out during the quarter.
  • Gould Capital sold 123 Boston Scientific shares in Q3 2024, an estimated $9.47K.
  • Gould Capital first reported a position in Boston Scientific in Q1 2022 and held it in 7 quarters.
  • Gould Capital's Boston Scientific position peaked at $1.12M in Q1 2022.
  • 1,395 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on Gould Capital's 13F filing for Q3 2024, filed 18 Nov 2024.